Alleviation of Alopecia after Switching from Escitalopram to Duloxetine: a Case Report

Essitalopram kullanımıyla gelişen ve duloksetine geçilmesiyle gerileyen alopesi: Olgu sunumu. Seçici serotonin geri alım inhibitörleri (SSGİ), lityum, karbamazepin, valproik asit (sodyum valproat), vigabatrin, antipsikotikler, benzodiazepinler, trisiklik antidepresanlar da dahil olmak üzere bir çok psikotrop ilacın saç kaybı ile ilişkili olduğu bildirilmiştir. İlaçlar hafif saç dökülmesinden saçların tamamen kaybına, hipertrikozisten hirsutizme kadar birçok saç hastalığına neden olabilir. Bu yazıda essitalopram kullanımıyla gelişen ve duloksetin tedavisine geçilmesiyle saç dökülmesi yan etkisi gerileyen bir olgu sunulmuş ve antidepresanlara bağlı alopesi ile ilgili alanyazın gözden geçirilmiştir.

Essitalopram kullanımıyla gelişen ve duloksetine geçilmesiyle gerileyen alopesi: Olgu sunumu

Alleviation of alopecia after switching from escitalopram to duloxetine: a case report. Many psychotropic drugs, including SSRIs, lithium, carbamazepine, valproate, vigabatrin, antipsychotics, benzodiazepines, and tricyclic antidepressants have been implicated in cases with alopecia. Drugs may cause a variety of dermatological side effects, ranging from mild hair loss to total alopecia, from hypertrichosis to hirsutism. In this paper, we present a case where alopecia emerged due to escitalopram, and where this side effect was alleviated after switching to duloxetine; we also review the literature for antidepressantrelated alopecia.

Kaynakça

Mercke Y, Sheng H, Khan T, Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000; 12:35-42. [CrossRef]

Yucel A, Karakus G, Gunasti S. Dermatological side effects of psychotropic drugs and treatment approaches. Bulletin of Clinical Psychopharmacology 2008; 18:235-244. (Turkish)

Warnock JK. Psychotropic medication and drug-related alopecia. Psychosomatics 1991; 32:149-152. [CrossRef]

Gautam M. Alopecia due to psychotropic medications. Ann Pharmacother 1999; 33:631-637. [CrossRef]

Pitchot W. Hair loss associated with escitalopram but not with venlafaxine: a case report. Prim Care Companion CNS Disord 2011; 13:1146. [CrossRef]

Jenike MA. Severe hair loss associated with fluoxetine use. Am J Psychiatry 1991; 148:392. [CrossRef]

Bhatara VS, Gupta S, Freeman JW. Fluoxetine associated paraesthesias and alopecia in a woman who tolerated sertraline. J Clin Psychiatry 1996; 57:227.

Ghanizadeh A. Sertraline-associated hair loss. J Drugs Dermatol 2008; 7:693-694.

Uzun O, Cansever A, Ozgen F. Hair loss due to sertraline use: a case report. Bulletin of Clinical Psychopharmacology 2003; 13:27-29. (Turkish)

Zalsman G, Sever J, Munitz H. Hair loss associated with paroxetine treatment: a case report. Clin Neuropharmacol 1999; 22:246-247.

Turkoglu S. Fluoxetine and sertraline related hair loss in a teenager: a case report. Bulletin of Clinical Psychopharmacology 2013; 23:77-80. [CrossRef]

Mermi O, Atmaca M, Kilic F, Gurok MG, Kuloglu M. Fluoxetine Induced Hair Loss: a case report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2014; 27:266-269. [CrossRef]

Unal E, Mete L, Gulseren L, Elikucuk B. Hair loss related to the fluvoxamine use: case reports. Reviews, cases and hypotheses in psychiatry (RHCP) 2008; 1-2:63-66.

Parameshwar E. Hair loss associated with fluvoxamine use. Am J Psychiatry 1996; 153:581-582. [CrossRef]

Hedenmalm K, Sundström A, Spigset O. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs). Pharmacoepidemiol Drug Saf 2006; 15:719-725. [CrossRef]

Rais T, Singh T, Rais A. Hair loss associated with long-term sertraline treatment in teenager. Psychiatry (Edgmont) 2005; 2:52.

Huang J, Gong Q, Li G, Lu S, Wang X. Serotonin in alopecia areata: an enzyme immunoassay study. Int J Dermatol 2004; 43:78-80. [CrossRef]

Kaynak Göster

  • ISSN: 1018-8681
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1984

4.8b 2.9b

Sayıdaki Diğer Makaleler

Psychometric Properties of the Inventory of Interpersonal Problems- Circumplex Scales Short Form: a Reliability and Validity Study

MİRAY AKYUNUS, TÜLİN GENÇÖZ

Tardive Dyskinesia in Mentally Retarded Patients under Long-Term Antipsychotic Treatment

Aylin CAN, Ahmet NALBANT, Huseyin Sehit BURHAN, Alparslan CANSİZ, Kaasım Fatih YAVUZ, Mehtap Arslan DELİCE, Erhan KURT

Reproductive and Sexual Functions in Bipolar Patients: Data from a Specialized Mood Disorder Clinic

EBRU ALDEMİR, Fisun AKDENİZ, Serhan IŞIKLI, Nesli Keskinoz BİLEN, Simavi VAHİP

Relation of the Nine Types of Temperament Model with Personality Disorders

Enver Demirel YILMAZ, Ali Görkem GENÇER, Özge ÜNAL, Mehmet PALANCI, Mehmet KANDEMİR, Ziya SELÇUK, ÖMER AYDEMİR

Alleviation of Alopecia after Switching from Escitalopram to Duloxetine: a Case Report

Sibel KOÇBIYIK, SEDAT BATMAZ, Levent TURHAN, Ozgur Ahmet YUNCU, Ali ÇAYKÖYLÜ

Tactile Hallucination and Delusion Following Acute Stroke: a Case Report

Erhan AKINCI, Fatih ÖNCÜ, Barış TOPÇULAR

Evaluation of Depression and Social Anxiety Symptoms in Obese Children

ESRA AKYÜZ ÖZKAN, Ali İrfan GÜL, Zeynep Tuba OZDEMİR, Hasim HUSREVSAHİ, Zehra YILDIRIM, Esra DOMUR, Ummugulsum Aliye GECİT

The Effect of Delusion and Hallucination Types on Treatment Response in Schizophrenia and Schizoaffective Disorder

Esin Evren KILIÇASLAN, Güler ACAR, Sevgin EKŞİOĞLU, Sermin KESEBİR, Ertan TEZCAN

Manifestation of Hashimoto's encephalopathy with Psychotic Signs: a Case Presentation

Ayşin KISABAY, Kuzeymen BALIKÇI, Serpil SARI, Deniz SELÇUKİ

Treatment Augmentation Effects of EMDR Intervention after Traumatic Experiences in Patients with Major Depression: a Case Series

Murat SEMİZ, Serdar ATİK, Murat ERDEM